Cargando…
Sclerostin as Regulatory Molecule in Vascular Media Calcification and the Bone–Vascular Axis
Sclerostin is a well-known inhibitor of bone formation that acts on Wnt/β-catenin signaling. This manuscript considers the possible role of sclerostin in vascular calcification, a process that shares many similarities with physiological bone formation. Rats were exposed to a warfarin-containing diet...
Autores principales: | De Maré, Annelies, Maudsley, Stuart, Azmi, Abdelkrim, Hendrickx, Jhana O., Opdebeeck, Britt, Neven, Ellen, D’Haese, Patrick C, Verhulst, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669501/ https://www.ncbi.nlm.nih.gov/pubmed/31330917 http://dx.doi.org/10.3390/toxins11070428 |
Ejemplares similares
-
Sclerostin Protects Against Vascular Calcification Development in Mice
por: De Maré, Annelies, et al.
Publicado: (2022) -
The Role of Sclerostin in Bone and Ectopic Calcification
por: De Maré, Annelies, et al.
Publicado: (2020) -
A Proteomic Screen to Unravel the Molecular Pathways Associated with Warfarin-Induced or TNAP-Inhibited Arterial Calcification in Rats
por: Opdebeeck, Britt, et al.
Publicado: (2023) -
Extracellular Nucleotides Regulate Arterial Calcification by Activating Both Independent and Dependent Purinergic Receptor Signaling Pathways
por: Opdebeeck, Britt, et al.
Publicado: (2020) -
New Therapeutics Targeting Arterial Media Calcification: Friend or Foe for Bone Mineralization?
por: Van den Branden, Astrid, et al.
Publicado: (2022)